HOME › DRUGS › ENTRECTINIB
ACTIVE SUBSTANCE / INN

ENTRECTINIB

Brand name(s): Rozlytrek, ROZLYTREK
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Cancer;Carcinoma, Non-Small-Cell Lung
NDA212726
ACTIVE SUBSTANCE
Entrectinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Roche Registration GmbH , GENENTECH INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ROZLYTREKNDA212726GENENTECH INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RozlytrekRoche Registration GmbH Authorised31/07/2020Cancer;Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON ENTRECTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →